medigraphic.com
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán

2023, Number 1

<< Back Next >>

Rev Biomed 2023; 34 (1)

Atypical presentation of cutaneous leishmaniasis in a patient with kidney transplant : approach and management based on a case report

Torres R, Rosselli C, Maricely R, Vasquez-Londoño A, Hernández M, Núñez E

Language: Spanish
References: 12
Page: 88-93
PDF size: 148.08 Kb.


ABSTRACT

Leishmaniasis is a zoonosis acquired by the bite of a female sandfly, which introduces leishmania promastigotes into the bloodstream. The clinical manifestations are determined by the host’s immunity, which ranges from a localized to a disseminated form. To date, several genera of sandflies have been identified, with Phlebotomus (Old World) and Lutzomyia (New World) being the most important for the transmission of leishmania spp. Diagnosis requires demonstration of the parasite in a sample obtained from a suspicious lesion using methods such as PCR, Giemsa stain, culture, among others. The management of leishmaniasis depends on the presentation and underlying cause. A case of cutaneous leishmaniasis associated with kidney transplant is presented, highlighting its clinical aspects, manifestations, histopathological findings, outcome and treatment.


REFERENCES

  1. Antinori S, Cascio A, Parravicini C, Bianchi R,Corbellino M. Leishmaniasis among organ transplantrecipients. Lancet Infect Dis. 2008 Mar;8(3):191-9. doi:10.1016/S1473-3099(08)70043-4

  2. Simon I, Wissing KM, Del Marmol V, Antinori S,Remmelink M, Nilufer Broeders E, et al. Recurrentleishmaniasis in kidney transplant recipients: Report of2 cases and systematic review of the literature. TransplInfect Dis. 2011 Aug;13(4):397-406. doi: 10.1111/j.1399- 3062.2011.00598.x

  3. Akuffo H, Costa C, van Griensven J, Burza S,Moreno J, Herrero M. New insights into leishmaniasisin the immunosuppressed. PLoS Negl Trop Dis.2018;12(5):e0006375. Published 2018 May 10.doi:10.1371/journal.pntd.0006375

  4. Gontijo CM, Pacheco RS, Orefice F, Lasmar E, SilvaES, Melo MN. Concurrent cutaneous, visceral andocular leishmaniasis caused by Leishmania (Viannia)braziliensis in a kidney transplant patient. Mem InstOswaldo Cruz. 2002 Jul;97(5):751-3. doi: 10.1590/s0074-02762002000500029.

  5. Zandieh A, Zandieh B, Dastgheib L. Dissemination oflocalized cutaneous leishmaniasis in an organ transplantrecipient: case report and literature review. Int JDermatol. 2013 Jan;52(1):59-62. doi: 10.1111/j.1365-4632.2012.05615.x

  6. Yaich S, Charfeddine K, Masmoudi A, Masmoudi M,Zaghdhane S, Turki H, et al. Atypical presentation ofcutaneous leishmaniasis in a renal transplant recipientsuccessfully treated with allopurinol and fluconazole.Ann Saudi Med. 2013 Mar-Apr;33(2):187-91. doi:10.5144/0256-4947.2012.01.7.1510

  7. Azeemi STY, Yasinzai M, Raza SM. A CaseHistory of Treatment of Cutaneous Leishmaniasisby Chromotherapy. Chin Med. 2011;02(02):43–6.doi:10.4236/cm.2011.22008

  8. Ministerio de salud y, prevención DDPY. Lineamientospara la atención clínica integral de leishmaniasis enColombia. 2018;(32).

  9. Hueso M, Bover J, Serón D, Gil-Vernet S, Rufí G,Alsina J, et al. The renal transplant patient with visceralleishmaniasis who could not tolerate me-glumineantimoniate - Cure with ketoconazole and allopurinol.Nephrol Dial Transplant. 1999 Dec;14(12):2941-3. doi:

  10. 10.1093/ndt/14.12.294110. Solomon M, Pavlotzky F, Barzilai A, Schwartz E.Liposomal amphotericin B in comparison to sodiumstibogluconate for Leishmania braziliensis cutaneousleishmaniasis in travelers. J Am Acad Dermatol. 2013Feb;68(2):284-9. doi: 10.1016/j.jaad.2012.06.014.

  11. Soto J, Soto P. Oral miltefosine to treat leishmaniasis.Biomedica. 2006 Oct;26 Suppl 1:207-17. PMID:17361856.

  12. González LM, Vélez ID. Tratamiento con miltefosina dela leishmaniosis cutánea diseminada. Biomédica. Oct.2006; 26(1):13-6.




2020     |     www.medigraphic.com